Cargando…
Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma
Metastatic melanoma is the most aggressive and obstinate skin cancer with poor prognosis. Variant novel applicable regimens have emerged during the past decades intensively, while the most profound approaches are oncogene-targeted therapy and T-lymphocyte mediated immunotherapy. Although targeted th...
Autores principales: | Yu, Chune, Liu, Xiaowei, Yang, Jiqiao, Zhang, Min, Jin, Hongyu, Ma, Xuelei, Shi, Hubing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513976/ https://www.ncbi.nlm.nih.gov/pubmed/31134073 http://dx.doi.org/10.3389/fimmu.2019.00990 |
Ejemplares similares
-
Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment
por: Luo, Ya, et al.
Publicado: (2020) -
Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
por: Wang, Xueyan, et al.
Publicado: (2022) -
Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II
por: Li, Yueyi, et al.
Publicado: (2023) -
Combining Immunotherapy with Oncogene-Targeted Therapy: A New Road for Melanoma Treatment
por: Aris, Mariana, et al.
Publicado: (2015) -
Case Report: Thrombotic-Thrombocytopenic Purpura Following Ipilimumab and Nivolumab Combination Immunotherapy for Metastatic Melanoma
por: Mullally, W. J., et al.
Publicado: (2022)